![](/img/cover-not-exists.png)
Cml patients with advanced phase disease retain clonogenic progenitor cells which are responsive to interferon alfa and STI571 in vitro
M.Y. Gordon, S.B. Marley, R.J. Davidson, D.X. Nguyen, J.L. Lewis, J.M. GoldmanVolume:
28
Year:
2000
Language:
english
Pages:
2
DOI:
10.1016/s0301-472x(00)00190-9
File:
PDF, 23 KB
english, 2000